Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02081482
Other study ID # 13-AOI-05
Secondary ID
Status Recruiting
Phase N/A
First received March 4, 2014
Last updated August 13, 2015
Start date March 2014
Est. completion date August 2016

Study information

Verified date July 2015
Source Centre Hospitalier Universitaire de Nice
Contact Michel LANTERI-MINET, PH
Phone 33 (0)4-92-03-79-46
Email lanteri-minet.m@chu-nice.fr
Is FDA regulated No
Health authority France: Committee for the Protection of Personnes
Study type Interventional

Clinical Trial Summary

The occipital nerve stimulation (ONS) is used to treat patients with refractory primary chronic headache but its mechanism of action (MoA) remains unknown. Different hypothesis have been suggested in particular a specific action on cerebral generators involved in different types of primary headaches or a non specific action on pain modulatory network.

The aim of this study, using the chronic cluster headache as a model, is to determine the changes in cerebral metabolism induced by ONS to precise its MoA in the treatment of primary chronic headache.


Recruitment information / eligibility

Status Recruiting
Enrollment 15
Est. completion date August 2016
Est. primary completion date July 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- age > 18 years

- chronic cluster headache (according to the IHS)

- refractory in who a treatment by ONS have been indicated

- patient affiliated at social security,

- informed consent signed

Exclusion Criteria:

- contraindication to MRI

- contraindication to 18F-FDG PET

- women without contraception/pregnant/breast-feeding

- patient non-compliant

- patient on legal guardianship

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms


Intervention

Radiation:
18F-FDG PET


Locations

Country Name City State
France CHU -Hôpital Gabriel Montpied Clermont Ferrand
France Institut des Neurosciences Marseille
France Département d'Evaluation et Traitement de la Douleur - Pôle Neurosciences Cliniques - Centre Hospitalo-Universitaire de Nice Nice
France Centre d'Urgence Céphalées Paris

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nice

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison of cerebral metabolism Changes of cerebral metabolism associated with ONS efficacy Baseline (before ONS), 1 week after ONS , 3 month after ONS No
See also
  Status Clinical Trial Phase
Recruiting NCT04814381 - Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA) Phase 4